MCL1 and small cell lung carcinoma: suggested that MCL1 inhibition therapy be applied for high MCL1- and low BCL-X L-expressing small-cell lung cancer patients (50), but it is unclear whether direct inhibition of MCL1 is also useful for sinonasal NC.